Dietary Fiber Intake Is Related to Skeletal Muscle Mass, Body Fat Mass, and Muscle-to-Fat Ratio Among People With Type 2 Diabetes: A Cross-Sectional Study.
body fat mass
dietary fiber intake
muscle to body fat ratio
skeletal muscle mass
type 2 diabetes
Journal
Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264
Informations de publication
Date de publication:
2022
2022
Historique:
received:
23
02
2022
accepted:
10
05
2022
entrez:
17
6
2022
pubmed:
18
6
2022
medline:
18
6
2022
Statut:
epublish
Résumé
To investigate the relationship between dietary fiber intake and skeletal muscle mass, body fat mass, and muscle-to-fat ratio (MFR) among men and women with type 2 diabetes (T2D). This cross-sectional study involved 260 men and 200 women with T2D. Percent skeletal muscle mass (%) or percent body fat mass (%) was calculated as (appendicular muscle mass [kg] or body fat mass [kg]/body weight [kg]) × 100. MFR was calculated as appendicular muscle mass divided by body fat mass. Information about dietary fiber intake (g/day) was obtained from a brief-type self-administered diet history questionnaire. Dietary fiber intake was correlated with percent body fat mass ( Dietary fiber intake was correlated with skeletal muscle mass, body fat mass, and MFR among women with T2D.
Identifiants
pubmed: 35711555
doi: 10.3389/fnut.2022.881877
pmc: PMC9194895
doi:
Types de publication
Journal Article
Langues
eng
Pagination
881877Informations de copyright
Copyright © 2022 Takahashi, Hashimoto, Kaji, Sakai, Kawate, Okamura, Okada, Kitagawa, Nakanishi, Majima, Osaka, Senmaru, Ushigome, Asano, Hamaguchi, Yamazaki and Fukui.
Déclaration de conflit d'intérêts
YH received personal fees from Novo Nordisk Pharma Ltd., Mitsubishi Tanabe Pharma Corp., Kowa Company Ltd., Sanofi K.K., Takeda Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., and Sumitomo Dainippon Pharma Co., Ltd., outside of the submitted work. HO received grant support from the Japan Society for the Promotion of Science, and personal fees from Daiichi Sankyo Co., Ltd., Takeda Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Novo Nordisk Pharma Ltd., MSD K.K., Kyowa Hakko Kirin Company Ltd., Kowa Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Ono Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., Sanofi K.K., and Mitsubishi Tanabe Pharma Corporation. NN received grant support from Japan Society for the Promotion of Science (JSPS KAKENHI grant numbers: 19K23999 and 20K16158) and the Japan Food Chemical Research Foundation, and personal fees from Novo Nordisk Pharma Ltd., and Kowa Pharmaceutical Co., Ltd. TOs received grants from Combi Corporation, and personal fees from Toa Eiyo Corp., Mitsubishi Tanabe Pharma Corp., Daiichi Sankyo Co., Ltd., Novo Nordisk Pharma Ltd., Nippon Boehringer Ingelheim Co., Ltd., Ono Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., MSD K.K., Takeda Pharmaceutical Co., Ltd., Kowa Pharma Co., LTD., Eli Lilly Japan K.K., and AstraZeneca K.K., outside of the submitted work. TS received personal fees from Kyowa Hakko Kirin Co., Ltd., Astellas Pharma Inc., Mitsubishi Tanabe Pharma Co., Kowa Pharma Co., Ltd., Sanofi K.K., Taisho Toyama Pharma Co., Ltd., Kissei Pharma Co., Ltd., MSD K.K., Novo Nordisk Pharma Ltd., Ono Pharma Co., Ltd., Eli Lilly Japan K.K., and Takeda Pharma Co., Ltd., outside of the submitted work. EU received grant support from the Japanese Study Group for Physiology and Management of Blood Pressure, Astellas Foundation for Research on Metabolic Disorders (grant number: 4024), Japan Society for the Promotion of Science, Mishima Kaiun Memorial Foundation, and personal fees from Sumitomo Dainippon Pharma Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Nippon Boehringer Ingelheim Co., Ltd., Sanofi K.K., Kowa Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Kyowa Hakko Kirin Co., Ltd., AstraZeneca K.K., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Ltd., and MSD K.K., outside of the submitted work. Donated Fund Laboratory of Diabetes therapeutics is an endowment department, supported with an unrestricted grant from Taiyo Kagaku Co., Ltd., Taisho Pharmaceutical Co., Ltd., and Ono Pharmaceutical Co., Ltd. MH received grants from Yamada Bee Farm, Oishi Kenko Inc., Nippon Boehringer Ingelheim Co., Ltd., AstraZeneca K.K., and Ono Pharma Co., Ltd., and personal fees from Eli Lilly, Japan, Sanofi K.K., Sumitomo Dainippon Pharma Co., Ltd., Daiichi Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corp., AstraZeneca K.K., Ono Pharma Co., Ltd., and Kowa Pharma Co., Ltd., outside of the submitted work. MA received personal fees from Takeda Pharmaceutical Co., Ltd., Kowa Pharmaceutical Co., Ltd., AstraZeneca K.K., Ono Pharmaceutical Co., Ltd., Abbott Japan Co., Ltd., Novo Nordisk Pharma Ltd., Chugai Pharmaceutical Co., Ltd., and Sumitomo Dainippon Pharma Co., Ltd., outside of the submitted work. MY received personal fees from Sumitomo Dainippon Pharma Co., Ltd., Kowa Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Kyowa Hakko Kirin Co., Ltd., Kowa Company, Limited, Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Ltd., AstraZeneca PLC, and MSD K.K., outside of the submitted work. MF received grants from Eli Lilly, Japan, K.K., Nippon Boehringer Ingelheim Co., Ltd., Sanwa Kagagu Kenkyusho Co., Ltd., Oishi Kenko Inc., MSD K.K., Kowa Pharma Co., Ltd., Kissei Pharma Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Ono Pharma Co. Ltd., Mitsubishi Tanabe Pharma Corp., Abbott Japan Co., Ltd., Daiichi Sankyo Co., Ltd., Johnson & Johnson K.K. Medical Co., Astellas Pharma Inc., Kyowa Kirin Co., Ltd., Novo Nordisk Pharma Ltd., Yamada Bee Farm, Taisho Pharma Co., Ltd., Terumo Corp., Takeda Pharma Co., Ltd., Tejin Pharma Ltd., Sanofi K.K., Nippon Chemiphar Co., Ltd., and TERUMO CORPORATION, and personal fees from Astellas Pharma Inc., Nippon Boehringer Ingelheim Co., Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., MSD K.K., Mochida Pharma Co., Ltd., Eli Lilly Japan K.K., Kissei Pharma Co., Ltd., AstraZeneca K.K., Mitsubishi Tanabe Pharma Corp., TERUMO CORPORATION, Daiichi Sankyo Co., Ltd., Bayer Yakuhin, Ltd., Takeda Pharma Co., Ltd., Teijin Pharma Ltd., Ono Pharma Co., Ltd., Taisho Pharma Co., Ltd., Kyowa Kirin Co., Ltd., Abbott Japan Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Arkray Inc., Medtronic Japan Co., Ltd., Novo Nordisk Pharma Ltd., Kowa Pharma Co., Ltd., Nipro Corp., and Sanofi K.K., outside of the submitted work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Obesity (Silver Spring). 2006 Feb;14(2):336-41
pubmed: 16571861
J Clin Biochem Nutr. 2014 Jan;54(1):7-11
pubmed: 24426184
J Nutr. 2009 Mar;139(3):576-81
pubmed: 19158230
Geriatr Gerontol Int. 2016 Feb;16(2):155-66
pubmed: 26271226
PLoS One. 2019 Aug 23;14(8):e0221366
pubmed: 31442231
Obes Surg. 2005 Aug;15(7):1082-3
pubmed: 16105412
Front Physiol. 2019 Nov 26;10:1435
pubmed: 31911785
PLoS One. 2014 Dec 17;9(12):e115407
pubmed: 25517117
Hypertension. 2009 Apr;53(4):577-84
pubmed: 19237685
Obes Rev. 2011 Sep;12(9):724-39
pubmed: 21676152
Nature. 2013 Dec 19;504(7480):446-50
pubmed: 24226770
Nat Rev Endocrinol. 2015 Oct;11(10):577-91
pubmed: 26260141
N Engl J Med. 2000 May 11;342(19):1392-8
pubmed: 10805824
BMC Geriatr. 2019 Jul 3;19(1):183
pubmed: 31269909
Endocr J. 2018 Apr 26;65(4):395-402
pubmed: 29375081
J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2
pubmed: 32033882
Obes Res. 1998 Apr;6 Suppl 1:8S-17S
pubmed: 9569171
J Am Geriatr Soc. 2002 May;50(5):889-96
pubmed: 12028177
Ann Nutr Metab. 2018;72(4):329-335
pubmed: 29730653
Diabetes. 2008 Jun;57(6):1470-81
pubmed: 18305141
J Epidemiol. 2012;22(2):151-9
pubmed: 22343326
Nature. 2006 Dec 21;444(7122):1027-31
pubmed: 17183312
Diabetes Care. 2011 Nov;34(11):2381-6
pubmed: 21926282
Nat Commun. 2013;4:1829
pubmed: 23652017
Geriatr Gerontol Int. 2015 Aug;15(8):1013-22
pubmed: 25345548
Geriatr Gerontol Int. 2019 Feb;19(2):153-158
pubmed: 30585390
Lancet. 2019 Feb 2;393(10170):434-445
pubmed: 30638909
J Cachexia Sarcopenia Muscle. 2020 Jun;11(3):726-734
pubmed: 32020762
J Diabetes Investig. 2019 Jan;10(1):108-117
pubmed: 29660782
J Clin Endocrinol Metab. 2012 Aug;97(8):E1451-7
pubmed: 22593589
J Am Med Dir Assoc. 2014 Dec;15(12):853-9
pubmed: 25455530
J Cachexia Sarcopenia Muscle. 2020 Jun;11(3):710-725
pubmed: 32030917
Curr Opin Clin Nutr Metab Care. 2012 Jan;15(1):12-22
pubmed: 22108098
Diabetes Care. 2009 Nov;32 Suppl 2:S157-63
pubmed: 19875544
Front Endocrinol (Lausanne). 2021 Nov 11;12:783363
pubmed: 34858351
Nutrients. 2020 Apr 13;12(4):
pubmed: 32295007
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):368-376
pubmed: 34866342
PLoS One. 2016 Jun 27;11(6):e0158055
pubmed: 27348124
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2134-2144
pubmed: 34585852
BMC Gastroenterol. 2015 Aug 11;15:100
pubmed: 26261039
J Lipid Res. 2013 Sep;54(9):2325-40
pubmed: 23821742
J Int Med Res. 1976;4(5):305-18
pubmed: 1028632
Public Health Nutr. 2011 Jul;14(7):1200-11
pubmed: 21477414
J Diabetes Metab Disord. 2017 May 16;16:21
pubmed: 28523252
FEBS J. 2017 Feb;284(4):517-524
pubmed: 27479876
Geriatr Gerontol Int. 2016 Mar;16(3):293-9
pubmed: 26799937
Endocr J. 2021 Jul 28;68(7):781-789
pubmed: 33731539
Nutrition. 2008 Oct;24(10):941-9
pubmed: 18562168
Am J Clin Nutr. 1992 Oct;56(4):616-22
pubmed: 1414959
Am J Clin Nutr. 2002 Jul;76(1):281S-5S
pubmed: 12081852
Calcif Tissue Int. 2020 Nov;107(5):453-463
pubmed: 32772138
Br J Sports Med. 2003;37(5):436-40
pubmed: 14514537
Biosci Biotechnol Biochem. 2009 Mar 23;73(3):570-6
pubmed: 19270372
J Diabetes. 2019 Jun;11(6):477-483
pubmed: 30407749
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
Proc Nutr Soc. 2015 Feb;74(1):13-22
pubmed: 25268552
J Diabetes Investig. 2015 Sep;6(5):533-42
pubmed: 26417410
Ann Intern Med. 1998 Feb 1;128(3):165-75
pubmed: 9454524
Front Med (Lausanne). 2017 Oct 04;4:167
pubmed: 29046874
Obesity (Silver Spring). 2012 Feb;20(2):349-55
pubmed: 22095115